Online IOP for College Students and Emerging Adults in MA
Treatment Resistance in Psychiatric Care
Understanding and Addressing Complex Psychiatric Challenges
What is Treatment Resistance?
Treatment resistance refers to the failure of conventional treatments to achieve desired outcomes, leaving individuals and clinicians searching for more effective approaches. The term itself is something of a misnomer because it locates the resistance in the patient and not in the treatment, where it belongs. Inadequacies in medication regimens, incomplete therapeutic strategies, or the lack of attention to underlying psychosocial factors can all play a role in treatment resistance. Patients labeled as “treatment resistant” frequently experience frustration, having tried multiple treatment modalities—such as medications, short-term therapy, or inpatient care—none of which helped them to take charge of their lives as they pursue recovery. Acknowledging the complexities of treatment resistance is the first step in developing possible solutions that can better address underlying causes.
Treatment Resistance and Comorbid Disorders
Comorbid conditions (more than one diagnosed disorder) significantly impact the effectiveness of treatments, often complicating the clinical picture and requiring more individualized interventions. These conditions include:
- Personality Disorders: Chronic maladaptive behaviors, such as those seen in Borderline Personality Disorder (BPD), interfere with treatment outcomes and recovery. BPD, characterized by unstable relationships, self-destructive behavior, and identity uncertainty, is frequently associated with treatment resistance. These enduring patterns create barriers to emotional regulation, making traditional therapies less effective without specialized intervention.
- Mood Disorders: Patients with chronic depression or bipolar disorder have often experienced early trauma, neglect, or abuse, which can predispose individuals to treatment-resistant symptoms. In many cases, psychotherapy has proven more effective than medication alone for addressing these deeply rooted issues (Nemeroff, et al. 2003). Bipolar disorder, in particular, may require a combination of intensive, longer-term psychosocial treatments alongside pharmacological care to achieve meaningful outcomes.
- Psychotic Spectrum Disorders: Despite advancements in psychopharmacology, many patients with schizophrenia or other psychotic disorders experience significant side effects or fail to respond adequately to available medications. Issues like weight gain, diabetes, and cardiovascular risks further complicate treatment adherence and efficacy. Roughly one-third of schizophrenia patients do not achieve sufficient improvement with even the most advanced pharmacological options, highlighting the need for alternative and integrative approaches.
Psychopharmacology
Medication adherence is a critical component of effective treatment, yet it is a common challenge in cases of treatment resistance. Patients may resist medications for various reasons, including side effects, fears that taking medications stigmatizes them, or the personal meanings they attach to taking medicine. At the Austen Riggs Center, our approach to pharmacotherapy, psychodynamic psychopharmacology, recognizes that adherence is about more than compliance—it involves addressing the emotional and psychological significance of medications for each individual. By working collaboratively to develop a mutually agreed-upon medication regimen, we help patients build trust and engagement in their treatment plan. This comprehensive approach fosters better outcomes by integrating medication use with psychotherapy, family treatment, and other therapeutic modalities. Our Director of Psychiatric Education and Associate Director of Training, David Mintz, MD, has authored a first-of-its-kind treatment manual entitled Psychodynamic Psychopharmacology: Caring for the Treatment-Resistant Patient.
How We Approach Treatment Resistance
The Austen Riggs Center specializes in complex, treatment-resistant cases, providing comprehensive, individualized care for patients who have struggled with traditional approaches. Our patients often have a history of failed treatments and face numerous challenges. Key statistics about our patients include:
- 80% have treatment-refractory mood disorders that have not responded to standard interventions.
- 50% have made at least one serious suicide attempt.
- 60% experienced early trauma, neglect, or abuse, which complicates their clinical presentation and influences their recovery journey.
Our integrative approach and unique open setting combines long-term psychotherapy, innovative psychopharmacology, and a focus on the unique psychosocial and emotional challenges each patient faces. This holistic method helps patients move beyond short-term symptom management, addressing the deeper issues that contribute to treatment resistance.
Research and Insights
The societal and economic burdens of treatment-resistant depression are real and staggering. Studies have highlighted the importance of considering psychosocial factors—such as early adverse experiences, comorbid conditions, and personal resilience—alongside biological treatments. For example:
- Studies reveal that 12-20% of patients with depression develop treatment-resistant symptoms, making it a significant public health concern.
- These patients have only a 20% probability of achieving remission, underscoring the need for innovative therapeutic approaches.
- Societal costs of treatment-resistant depression range between $29 and $48 billion annually, with total depression costs surpassing $188 billion.
Treatment resistance is not solely a patient issue but reflects the limitations of the field’s traditional focus on biological treatments. Addressing this requires expanding the lens to include psychotherapy and other psychosocial interventions, like the ones offered at the Austen Riggs Center, where we offer evidence-based, holistic care that prioritizes the dignity and autonomy of each patient.
Former Patient Stories
Hear first-hand from Austen Riggs Center Alumni about their experiences before, during, and after treatment at Riggs.
The Riggs Difference
At Riggs, you’ll find an open setting that promotes patient autonomy as you uncover the meanings behind your symptoms through a therapist-patient relationship and a community of people dedicated to mutual learning and support.
Admission Process
If you’re thinking about Riggs treatment for yourself or a family member suffering mental health issues, please contact Admissions for more information. Clinicians: If you are considering referring a patient to Riggs, please contact Admissions to begin the process.
Learn More About Admission
Speak with Admissions
If you’re ready to take the first step toward recovery at Riggs, please contact us.
Patient Outcomes & Results